Aegerion Pharmaceuticals, Inc. 4
4 · Aegerion Pharmaceuticals, Inc. · Filed Apr 3, 2015
Insider Transaction Report
Form 4
Andrews William T.
See Remarks
Transactions
- Award
Stock Option (right to buy)
2015-04-01+27,000→ 27,000 totalExercise: $26.00Exp: 2025-04-01→ Common Stock (27,000 underlying) - Award
Restricted Stock Units
2015-04-01+7,000→ 7,000 total→ Common Stock (7,000 underlying)
Footnotes (4)
- [F1]The stock option award has an exercise price equal to the fair market value of the closing price of the Issuer on the date of the grant.
- [F2]25% of the shares of common stock underlying this stock option award will vest on April 1, 2016. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through April 1, 2019, subject to the Reporting Person's continued employment with the Issuer.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F4]The restricted stock units will vest in three annual installments, with 33.34% of the units vesting on April 1, 2016, 33.33% of the units vesting on April 1, 2017, and 33.33% of the units vesting on April 1, 2018, subject to the Reporting Person's continued employment with the Issuer.